TD Asset Management’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.94M | Buy |
496,290
+187,710
| +61% | +$2.63M | 0.01% | 717 |
|
|
2025
Q1 | $4.2M | Buy |
308,580
+42,828
| +16% | +$582K | ﹤0.01% | 810 |
|
|
2024
Q4 | $5.42M | Buy |
265,752
+21,200
| +9% | +$432K | ﹤0.01% | 784 |
|
|
2024
Q3 | $7.2M | Buy |
244,552
+65,400
| +37% | +$1.92M | 0.01% | 707 |
|
|
2024
Q2 | $4.16M | Buy |
179,152
+7,766
| +5% | +$180K | ﹤0.01% | 800 |
|
|
2024
Q1 | $3.52M | Buy |
171,386
+80,342
| +88% | +$1.65M | ﹤0.01% | 854 |
|
|
2023
Q4 | $1.95M | Sell |
91,044
-43,956
| -33% | -$943K | ﹤0.01% | 1020 |
|
|
2023
Q3 | $2.79M | Buy |
135,000
+50,578
| +60% | +$1.04M | ﹤0.01% | 866 |
|
|
2023
Q2 | $2.49M | Sell |
84,422
-3,900
| -4% | -$115K | ﹤0.01% | 910 |
|
|
2023
Q1 | $2.03M | Sell |
88,322
-10,887
| -11% | -$251K | ﹤0.01% | 976 |
|
|
2022
Q4 | $2.76M | Buy |
99,209
+5,086
| +5% | +$141K | ﹤0.01% | 896 |
|
|
2022
Q3 | $2.76M | Sell |
94,123
-27,100
| -22% | -$794K | ﹤0.01% | 907 |
|
|
2022
Q2 | $3.57M | Sell |
121,223
-11,814
| -9% | -$348K | ﹤0.01% | 849 |
|
|
2022
Q1 | $4.28M | Buy |
133,037
+10,700
| +9% | +$344K | ﹤0.01% | 861 |
|
|
2021
Q4 | $5.46M | Sell |
122,337
-4,500
| -4% | -$201K | ﹤0.01% | 844 |
|
|
2021
Q3 | $6.4M | Hold |
126,837
| – | – | 0.01% | 763 |
|
|
2021
Q2 | $6.47M | Sell |
126,837
-14,000
| -10% | -$714K | 0.01% | 765 |
|
|
2021
Q1 | $8.04M | Buy |
140,837
+7,013
| +5% | +$400K | 0.01% | 694 |
|
|
2020
Q4 | $11.2M | Buy |
133,824
+34,880
| +35% | +$2.92M | 0.01% | 555 |
|
|
2020
Q3 | $3.55M | Buy |
98,944
+41,337
| +72% | +$1.48M | ﹤0.01% | 795 |
|
|
2020
Q2 | $1.39M | Buy |
57,607
+24,900
| +76% | +$602K | ﹤0.01% | 959 |
|
|
2020
Q1 | $573K | Buy |
32,707
+8,707
| +36% | +$153K | ﹤0.01% | 1143 |
|
|
2019
Q4 | $418K | Hold |
24,000
| – | – | ﹤0.01% | 1275 |
|
|
2019
Q3 | $368K | Sell |
24,000
-500
| -2% | -$7.67K | ﹤0.01% | 1224 |
|
|
2019
Q2 | $509K | Buy |
24,500
+1,100
| +5% | +$22.9K | ﹤0.01% | 1178 |
|
|
2019
Q1 | $543K | Buy |
23,400
+500
| +2% | +$11.6K | ﹤0.01% | 1175 |
|
|
2018
Q4 | $473K | Buy |
22,900
+500
| +2% | +$10.3K | ﹤0.01% | 1237 |
|
|
2018
Q3 | $487K | Buy |
22,400
+6,000
| +37% | +$130K | ﹤0.01% | 1294 |
|
|
2018
Q2 | $250K | Hold |
16,400
| – | – | ﹤0.01% | 1367 |
|
|
2018
Q1 | $323K | Buy |
+16,400
| New | +$323K | ﹤0.01% | 1270 |
|